This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
Analog 13 showed MIC = 4 µg/mL against E. coli and 36% hemolysis at 150 µM.
Why it matters
The findings could lead to new treatments for infections caused by antibiotic-resistant bacteria, which are a growing public health concern.
How the study worked
The study involved synthesizing peptide analogs and testing their antimicrobial activity against various bacteria.
What this study cannot tell us
The study primarily focused on in vitro testing, which may not fully predict effectiveness in humans.
Read the original research
C-Locked Analogs of the Antimicrobial Peptide BP214.
Antibiotics (Basel, Switzerland), 11(8)
Citation
Andersen, Ida Kristine Lysgaard; Thomsen, Thomas T; Rashid, Jasmina; Bobak, Thomas Rønnemoes; Oddo, Alberto; Franzyk, Henrik; Løbner-Olesen, Anders; Hansen, Paul R. (2022). C-Locked Analogs of the Antimicrobial Peptide BP214.. Antibiotics (Basel, Switzerland), 11(8). https://doi.org/10.3390/antibiotics11081080